176 related articles for article (PubMed ID: 15039395)
1. Researchers report findings on HIV drug resistance, new infections.
Stephenson J
JAMA; 2004 Mar; 291(12):1431-3. PubMed ID: 15039395
[No Abstract] [Full Text] [Related]
2. Perinatal HIV prevention aims for elimination.
AIDS Read; 2002 Apr; 12(4):146, 150. PubMed ID: 12071183
[No Abstract] [Full Text] [Related]
3. Mother-to-child HIV transmission and ARVs.
de Vlas SJ; Nagelkerke NJ; Jha P; Plummer FA
Science; 2002 Dec; 298(5601):2129. PubMed ID: 12481779
[No Abstract] [Full Text] [Related]
4. Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India.
Jacob MS; Durairaj A; Vijayakumari J; Srijayanth P; Sivakumar MR
Indian J Pathol Microbiol; 2011; 54(2):359-61. PubMed ID: 21623090
[TBL] [Abstract][Full Text] [Related]
5. Nevirapine may promote resistance.
AIDS Patient Care STDS; 2004 Apr; 18(4):249-50. PubMed ID: 15154406
[No Abstract] [Full Text] [Related]
6. HIVNET 012 and Petra.
Cooper E
Lancet; 2004 Jan; 363(9404):244; author reply 245-6. PubMed ID: 14738806
[No Abstract] [Full Text] [Related]
7. Management of human immunodeficiency virus infection in pregnancy.
Watts DH
N Engl J Med; 2002 Jun; 346(24):1879-91. PubMed ID: 12063373
[No Abstract] [Full Text] [Related]
8. HIVNET 012 and Petra.
Wilfert CM
Lancet; 2004 Jan; 363(9404):244-5; author reply 245-6. PubMed ID: 14738805
[No Abstract] [Full Text] [Related]
9. Single-dose nevirapine to prevent mother-to-child transmission of HIV type 1: balancing the benefits and risks.
Mellors JW; Chow JY
Clin Infect Dis; 2009 Feb; 48(4):473-5. PubMed ID: 19133800
[No Abstract] [Full Text] [Related]
10. Preventing HIV infection in children.
Steinbrook R
N Engl J Med; 2002 Jun; 346(24):1842-3. PubMed ID: 12063367
[No Abstract] [Full Text] [Related]
11. Risk of archived resistance after intrapartum nevirapine.
S Afr Med J; 2004 May; 94(5):334-5. PubMed ID: 15211942
[No Abstract] [Full Text] [Related]
12. High genetic barrier antiretroviral drugs in human immunodeficiency virus-positive pregnancy.
Zazzi M
Clin Infect Dis; 2010 Mar; 50(6):895-7. PubMed ID: 20166822
[No Abstract] [Full Text] [Related]
13. [German-Austrian guidelines for HIV therapy during pregnancy (May, 2001, update].
Buchholz B; ;
Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S19-31. PubMed ID: 12736864
[No Abstract] [Full Text] [Related]
14. Averting drug resistance while preventing MTCT.
AIDS Read; 2005 Apr; 15(4):150-1. PubMed ID: 15846848
[No Abstract] [Full Text] [Related]
15. Establishment of drug-resistant HIV-1 in latent reservoirs.
Dahl V; Palmer S
J Infect Dis; 2009 May; 199(9):1258-60. PubMed ID: 19338473
[No Abstract] [Full Text] [Related]
16. Beginning to make progress against HIV.
Wilfert CM
N Engl J Med; 1996 Nov; 335(22):1678-80. PubMed ID: 8929367
[No Abstract] [Full Text] [Related]
17. Mode of delivery and the risk of vertical transmission of HIV-1.
Beckerman KP; Morris AB; Stek A
N Engl J Med; 1999 Jul; 341(3):205-6; author reply 206-7. PubMed ID: 10409037
[No Abstract] [Full Text] [Related]
18. FDA notifications. Revised guidelines for pregnant women.
AIDS Alert; 2007 Dec; 22(12):141. PubMed ID: 18411483
[No Abstract] [Full Text] [Related]
19. The interface of perinatal HIV prevention, antiretroviral drug resistance, and antiretroviral treatment: what do we really know?
Fowler MG; Mofenson L; McConnell M
J Acquir Immune Defic Syndr; 2003 Nov; 34(3):308-11. PubMed ID: 14600577
[No Abstract] [Full Text] [Related]
20. [HIV, desire to have a child and pregnancy: new aspects].
Gingelmaier A
MMW Fortschr Med; 2016 Jun; 158 Suppl 1():46-8. PubMed ID: 27259903
[No Abstract] [Full Text] [Related]
[Next] [New Search]
